Holen Sie sich die Stockscreener-App
10.14
0.35%
0.035
Schlusskurs vom Vortag:
$10.11
Offen:
$10.115
24-Stunden-Volumen:
400
Relative Volume:
0.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.10%
1M Leistung:
+0.60%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.09
$10.15
1-Wochen-Bereich:
$10.08
$10.15
52-Wochen-Spanne:
$10.00
$10.82
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
Firmenname
Drugs Made In America Acquisition Corp
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie DMAAU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.14 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.675 | 2.25B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.17 | 696.88M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.62 | 458.10M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.23 | 449.41M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.04 | 447.53M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Aktie (DMAAU) Neueste Nachrichten
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
Q1 Earnings Estimate for WSP Global Issued By Raymond James - Defense World
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
adidas AG (OTCMKTS:ADDYY) Sees Large Growth in Short Interest - Defense World
ACS, Actividades de Construcción y Servicios, S.A. (OTCMKTS:ACSAY) Short Interest Up 104.9% in February - Defense World
Acorn Energy, Inc. (OTCMKTS:ACFN) Sees Large Increase in Short Interest - Defense World
Smithfield Foods, Inc’s (NASDAQ:SFD) Quiet Period Set To Expire on March 10th - Defense World
Short Interest in ANA Holdings Inc. (OTCMKTS:ALNPY) Decreases By 33.3% - Defense World
Alfa S.A.B. de C.V. (OTCMKTS:ALFFF) Short Interest Up 79.6% in February - Defense World
AIA Group Limited (OTCMKTS:AAGIY) Short Interest Update - Defense World
Aker ASA (OTCMKTS:AKAAF) Short Interest Up 61.0% in February - Defense World
Athena Gold Co. (OTCMKTS:AHNR) Sees Significant Growth in Short Interest - Defense World
Short Interest in Agricultural Bank of China Limited (OTCMKTS:ACGBF) Increases By 74.0% - Defense World
Short Interest in Alaris Equity Partners Income Trust (OTCMKTS:ADLRF) Grows By 137.9% - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Update - Defense World
Financial Comparison: Thomasville Bancshares (OTCMKTS:THVB) & U.S. Bancorp (NYSE:USB) - Defense World
OSI Systems (NASDAQ:OSIS) vs. Applied Optoelectronics (NASDAQ:AAOI) Critical Contrast - Defense World
Endava plc (NYSE:DAVA) Receives $39.10 Consensus Target Price from Brokerages - Defense World
Sanctuary Advisors LLC Has $782,000 Stake in Vornado Realty Trust (NYSE:VNO) - Defense World
Drugs Made in America Acquisition Corp. Announces Advisory Team - The Manila Times
CanadaHelps Estimates $266 Million Loss for Charities Due to Canada Post Strike; Urges Canadians to Use Extended Donation Deadline to Give - The Manila Times
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Can This Power Team of Healthcare Veterans Reshape American Drug Manufacturing? - StockTitan
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com
SPAC Alert: Key Trading Change Coming for Drugs Made In America UnitsWhat Investors Should Track - StockTitan
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - The Manila Times
Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com
ForexTV | Small Business Resources - ForexTV.com
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO ... - The Bakersfield Californian
Nortech Systems (NASDAQ:NSYS) Coverage Initiated by Analysts at StockNews.com - Defense World
Roy Twite Purchases 8 Shares of IMI plc (LON:IMI) Stock - Defense World
U.S. investors, Big Pharma race to find new medicines in China - CNBC
Drugs Made In America Acquisition Corp.’s $200 Million Initial Public Offering - Global Legal Chronicle
Pharma Co. Misled Investors On Depression Drug, Suit Says - Law360
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF (BATS:BBAX) Stock Price Up 3.3% – Time to Buy? - Defense World
Initial Public Offering (IPO) News Live Feed - StockTitan
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Business Wire
Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - FiercePharma
United Parcel Service (UPS) | History, Services, & Facts - Britannica
Mountain Commerce Bancorp (OTCMKTS:MCBI) Stock Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Our History - Baxter
Barclays Cuts Lennar (NYSE:LEN) Price Target to $121.00 - Defense World
IPO NewsUS IPO Weekly Recap: Active January closes out with several sizable IPOs - Renaissance Capital
Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) Successfully Completes $200 Million IPOFort Lauderdale, FL, Jan. 29, 2025 – Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) recently announced the successful closure of its initial - Defense World
Sellas Life Sciences Group Announces $25 Million Registered Direct Offering - Defense World
Allogene Therapeutics, Inc. Announces Departure of Timothy MooreOn January 23, 2025, Allogene Therapeutics, Inc. (NASDAQ: ALLO) revealed in an 8-K filing that Timothy Moore, the Company’s incumbent executive, would be concluding his tenure with the - Defense World
Finanzdaten der Drugs Made In America Acquisition Corp-Aktie (DMAAU)
Es liegen keine Finanzdaten für Drugs Made In America Acquisition Corp (DMAAU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):